A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics. (Q51016895)
Jump to navigation
Jump to search
scientific article published on 4 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics. |
scientific article published on 4 May 2013 |
Statements
A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics. (English)
1 reference
1 reference
Rafael Rosell
1 reference
Cesare Gridelli
1 reference
Jean-Yves Douillard
1 reference
Vassilis Georgoulias
1 reference
David Khayat
1 reference
Christian Manegold
1 reference
Jeanne Menez-Jamet
1 reference
Marina Iché
1 reference
Kostas Kosmatopoulos
1 reference
4 May 2013
1 reference
14
1 reference
4
1 reference
461-465
1 reference